Trial intelligence / Profile preview

QP002 gel for postoperative pain after thoracoscopic thoracic surgery

ChiCTR2300075666Phase 2Recruiting

Sponsor
Sichuan Provincial Academy of Medical Sciences and Sichuan People's Hospital
Start
Mar 2023
Modality
Small Molecules, Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of QP002 in postoperative pain (8 arms), sponsored by Sichuan Provincial Academy of Medical Sciences and Sichuan People's Hospital. Primary endpoint: Total morphine consumption. Started Mar 2023; status: recruiting.

02

Drugs

QP002
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2300075666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300075666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call